These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8038494)

  • 21. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
    Robak T; Kasznicki M
    Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
    Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
    J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
    Robak T
    Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.
    Tam C; Kuss B; Opat S; Boulos J; Marlton P
    Intern Med J; 2017 Jul; 47 Suppl 4():5-10. PubMed ID: 28685928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic lymphocytic leukemia treatment.
    Dighiero G
    Hematol Cell Ther; 1997 Nov; 39 Suppl 1():S31-40. PubMed ID: 9471059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study.
    Hansen MM; Andersen E; Christensen BE; Christiansen I; Geisler C; Kristensen D; Jensen KB; Junker P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):433-6. PubMed ID: 3065739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia.
    Leporrier M
    Hematol J; 2004; 5 Suppl 1():S10-9. PubMed ID: 15079149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
    Levy V; Porcher R; Delabarre F; Leporrier M; Cazin B; Chevret S;
    J Clin Epidemiol; 2001 Jul; 54(7):747-54. PubMed ID: 11438417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
    Prescrire Int; 2005 Feb; 14(75):3-5. PubMed ID: 15747447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.
    Robak T
    Leuk Lymphoma; 2002 Mar; 43(3):537-48. PubMed ID: 12002757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The experience of the French Cooperative Group in the treatment of CLL.
    Travade P
    Nouv Rev Fr Hematol (1978); 1990; 32(5):313-7. PubMed ID: 2099402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fludarabine in chronic lymphocytic leukaemia.
    Elter T; Hallek M; Engert A
    Expert Opin Pharmacother; 2006 Aug; 7(12):1641-51. PubMed ID: 16872267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic lymphatic leukemia].
    Lechner K; Bilbeisi S; Wittmann E; Wilfing A
    Wien Klin Wochenschr; 1994; 106(10):291-9. PubMed ID: 8053196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
    Bosanquet AG; McCann SR; Crotty GM; Mills MJ; Catovsky D
    Acta Haematol; 1995; 93(2-4):73-9. PubMed ID: 7543720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.